Healthcare

Air Liquide is one of the world leaders in this business sector, which is subject to both stringent regulatory requirements as well as to multiple stakeholders (patients, doctors and payers). The business line provides products and services in three areas:

• Medical gases: Air Liquide provides gases to 15,000 hospitals and clinics
• Home healthcare: Air Liquide cares for more than 1.8 million patients in their homes suffering from chronic diseases
• Healthcare specialty ingredients through its subsidiary Seppic

The Healthcare activity, in particular Medical Gases, mainly relies on the gas production capacities of Large Industries and develops its own distribution logistics. Medical gases have a drug designation status which requires market authorization from the country’s health authorities. They are subject to specific pharmaceutical traceability and are supplied in gas or liquid form by qualified personnel. The integration of the Industrial and Healthcare activities has led to synergies and industrial efficiency.Over the last 20 years, Air Liquide strengthened a leading healthcare role in Western Europe, Canada and Australia. The Group also has businesses in the United States (medical gases only), South America and certain Asian, African and Eastern European countries. It continues to grow in all regions, in particular according to the expansion of healthcare systems. As a result, approximately 71% of the Healthcare business line’s sales are in Europe and around 22% in the Americas.

The continuum of care